ANRASSF1与肿瘤的研究进展

doi:10.3969/j.issn.1674-5671.2019.06.16

Abstract

CLC Number:

HUANG Xiancong, WANG Changchun, MAO Weimin. Research progress of ANRASSF1 and tumors [J].Chinese Journal of Oncology Prevention and Treatment, 2019, 11(6): 532-535.

[1]	Tumor marker committee of China Anti-Cancer Association, Integrative Oncology Branch of the China Anti-Cancer Association. China expert consensus on diagnosis and treatment of lymphoepithelial carcinoma (2025 edition) [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 1-10.
[2]	Integrated Chinese and Western Medicine Ovarian Cancer Specialty Committee of China Anti-Cancer Association. China expert consensus on diagnosis and treatment of low-grade serous ovarian cancer (2024 edition) [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 11-20.
[3]	LIANG Shuang, XIE Yuanliang, FENG Chao, LU Qinchen, TAO Yuting, LV Yuqi, LI Tianyu, WANG Qiuyan, TANG Shaomei. Analyzing the impact of lncRNA MBNL1-AS1 on the molecular characteristics of Basal subtype muscle-invasive bladder cancer based on omics technologies [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 21-29.
[4]	ZHANG Shiyi, SUN Jiamin, ZHONG Jianhong, WANG Qiuyan, TAO Yuting. Clinical significance of YAP signaling activation in extracellular matrix remodeling in hepatocellular carcinoma and its molecular mechanisms [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 30-39.
[5]	LI Meng, LI Pingchuan, LIU Xiaoqiang, YANG Huawei. Effects of MCM5 knockdown on proliferation,migration and apoptosis of breast cancer cells [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 40-47.
[6]	LI Lei, LIU Xiaodan, ZHOU Kaixiang, HE Linjie, ZHANG Jian, CHEN Qiang, MENG Han, FENG Huan, ZHANG Wenming, LU Jun, ZHOU Feng, CUI Hongzun, NIU Wancheng, ZHANG Zhaohui. Effects of ischemia postconditioning on mitochondrial function in rats and its protective mechanisms in hepatic ischemia-reperfusion injury [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 48-54.
[7]	JIANG Lu, ZHANG Zhidong, WU Jianjun, LIU Lu, SHANG Longjian, WEI Xingmin . Changing trends in the disease burden of liver cancer in China and the United States from 1990 to 2021 and its predictions [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 55-60.
[8]	WANG Haodi, DENG Zhengming, WANG Gang, JIANG Zhiwei. Disease burden in colorectal cancer attributed to fasting hyperglycemia in china from 1990 to 2021 and projections of future trends [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 61-67.
[9]	CAO Le, MA Minmin, LI Wenmin, SHUI Mingming, JIANG Cheng. Trend of mortality and disease burden of gastric cancer in China,2004—2021 [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 68-73.
[10]	CHEN Xiaodan, ZHOU Shu, LYU Yanru, XU Zhiyong, LAN Haiyan, LU Shui, GAO Shan, SHU Liuyang, LIN Siyang, HAO Yanrong, XIE Yanyan. Study on the initial titration dose and genetic polymorphism of oxycodone hydrochloride prolonged-release tablets in the treatment of severe cancer pain [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 74-80.
[11]	ZENG Lijie, WANG Liang, YANG Lei . Clinical features and treatment efficacy analysis of central nervous system involvement in extranodal nasal-type natural killer/T-cell lymphoma [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 81-87.
[12]	TAN Xiaoning, ZHANG Tianwen, LIU Bin, ZHAO Chang. Clinical application value of preoperative interventional embolization in total en-bloc spondylectomy for spinal tumors [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 88-94.
[13]	JIA Yingguo, LUO Pengfei, MA Wei, DONG Jinmin, JIAO Dahai. Development of cancer-specific survival prediction model and risk stratification for patients aged ≥55 years with N1b stage papillary thyroid carcinoma based on the SEER database [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 95-102.
[14]	YANG Jun, KANG Wei, ZHONG Wuning, ZHAO Xin. Predictive value of radiomics model based on cone-beam breast CT images for pathological complete response of neoadjuvant therapy in breast cancer [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 103-108.
[15]	ZHANG Yuanfen, LONG Ying, YAO Desheng. Relationship between perineural invasion,clinical pathological characteristics of cervical cancer and its effects on prognosis [J]. Chinese Journal of Oncology Prevention and Treatment, 2025, 17(1): 109-114.

Research progress of ANRASSF1 and tumors

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0